GHK CU NASAL SPRAY
Your body already knows how to repair itself.
GHK-Cu is not a foreign molecule. It is a naturally occurring copper peptide your body produced in abundance in your 20s. By 60, it is nearly undetectable in plasma. AEGIS returns it systemically — through the bloodstream, not as a surface application.
GHK-Cu
Copper Tripeptide-1 peaks in youth and undergoes sharp age-related decline. At therapeutic levels it activates the gene network governing collagen synthesis, VEGF-driven tissue repair, anti-inflammatory cytokine regulation, and hair follicle regeneration. This is the Pickart research at a real dose.
Hair shedding slows.
GHK-Cu reaches scalp follicles through systemic circulation. The first observable signal is typically reduced hair loss — not a surface treatment, a signaling shift.
Skin texture begins shifting.
New collagen production becomes measurable. Skin feels structurally different — not moisturized, but rebuilt.
Visible structural change.
Collagen density improves. Follicle response becomes visible. Results accumulate because they are biological, not topical.
AEGIS is systemic — it reaches every tissue through your bloodstream. GLOW works at the surface of the skin where it is applied. For comprehensive results, both are used concurrently.
GHK-Cu gene modulation research was conducted at concentrations achievable with consistent nasal delivery. Dose and consistency are both required. One spray per nostril daily is the protocol.
GHK-Cu is a naturally occurring tripeptide. No known interactions with common medications. Consult your healthcare provider if you are under active treatment for an inflammatory condition.